About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials | 4,006 Studies Recruiting

Clinical TrialsCOVID-19

COVID-19 Clinical Trials

Browse 4,006 clinical trials for covid-19. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 4,006 trials

CompletedCancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)People with cancer may be at higher risk of poor outcomes with COVID-19 infection.NCT04427280·Sutton, Surrey CompletedStudy on the Performance and Safety of Sentinox in COVID-19 PatientsThis is a single-center, randomized, controlled, open-label, pilot study to assess the safety and the performance of Sentinox medical device in the treatment of mild COVID-19…NCT04909996·Genova

Related Searches

covid-19trials coronavirustrials sars-cov-2trials

Data from ClinicalTrials.govTerms

CompletedAn Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in JapanThis is an observational, cohort study that will use secondary data to describe the baseline demographics and clinical characteristics in patients who received EVUSHELD as PrEP…NCT06156982·Osaka

CompletedSeroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for SurgeryWe have herein analysed the patients admitted to our Department that underwent serologic tests for SARS-CoV-2 either by Ab or RT PCR, to estimate the prevalence of COVID-19 in the…NCT04480580·Cagliari, CA

CompletedAssessment of Stress and Associated Factors Among Young Adults During the COVID-19 PandemicSince the onset of COVID-19, studies conducted on the general population have shown an increase in the use of antidepressants and anxiolytics, a rise in domestic violence, and…NCT07845396·Nanterre

UnknownImpact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe DiseaseBackground:The impact of the emergence of SARS-CoV-2 variants on the severity and clinical outcomes of COVID-19 is controversial.NCT05162508·Créteil, Val De Marne

CompletedA Web-based Platform to Improve Physical Function, Nutrition, and Mindfulness in Patients With Long COVIDPatients with COVID-19 may experience prolonged physical and psychological symptoms after weeks or months of the infection.NCT05422924·Edmonton, Alberta

UnknownEstablishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 VaccineCOVID-19 vaccines are limited in supply, especially in low- and middle-income countries, leading to substantial morbidity and mortality.NCT05315362·Leiden

CompletedEfficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe DiseaseThe purpose of this study is to assess the efficacy of N-acetylcysteine (NAC) in preventing those with mild or moderate COVID-19 from progressing to severe diseaseNCT04419025·Cambridge, Massachusetts and 3 others

Not yet recruitingImbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19Investigation of the correlation of CT-morphological changes of the lung compared to regional ventilation distribution on electrical impedance tomography in patients with…NCT05238623·Jena, Thuringia

UnknownCoagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 InfectionOn 30 January 2020, WHO declared the SARS-CoV-2 outbreak as a public health emergency of international concern.NCT04624997·Paris and 1 other

UnknownFavipiravir in Hospitalized COVID-19 PatientsThe present study is a randomized, double-blind, controlled, clinical trial, with the approval of the ethics committee will be conducted on patients who have a positive test…NCT04359615·Tehran

RecruitingCare for Veterans Post-COVID-19The evidence-based Concordant Care approach involves engaging in processes that: 1) validate the patient's experience, 2) develop a shared understanding of the condition, and 3)…NCT05787379·East Orange, New Jersey

UnknownSaxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and StaffTo investigate short- (3 and 8 weeks) and long-term (6, 9, 12, and 18 months) immune protection or response at the humoral and cellular levels before and after SARS-CoV-2…NCT04799808·Dresden, Saxony

CompletedHydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19This study will compare two drugs (hydroxychloroquine and azithromycin) to see if hydroxychloroquine is better than azithromycin in treating hospitalized patients with suspected…NCT04329832·Murray, Utah and 1 other

CompletedA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsThe study is divided into 2 parts: Part 1 and Part 2.NCT05827926·Chandler, Arizona and 68 others

CompletedAnalysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult PatientsNon-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in adults.NCT04492384·Moscow

RecruitingDevelopment of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron SubvariantsCOVHIC003 is a human infection challenge study in which healthy adults aged 18-50 previously vaccinated with an approved COVID-19 vaccine will be administered a SARS-CoV-2 Omicron…NCT07397455·London and 4 others

UnknownClinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)Popular topic：Clinical study on the immune program of recombinant Novel Coronavirus (COVID-19) vaccine (CHO cell).NCT05128643·Changsha, Hunan

CompletedScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19Purpose: To determine the number of asymptomatic individuals who have antibodies to SARS-CoV-2, the virus which causes COVID-19NCT04367740·Chapel Hill, North Carolina

PreviousPage 4 of 201Next